Ambar Protein Industries Reports Mixed Q2 FY2026 Results with Revenue Dip and Profit Decline

Ambar Protein Industries Limited , a player in the protein industry, has released its unaudited financial results for the second quarter of fiscal year 2026, ending September 30, 2025. The company's performance shows a mixed picture with a slight decline in revenue and a more pronounced drop in profitability compared to the previous quarter.

Revenue and Profitability

The company reported a total income of Rs 11,314.95 lakhs for Q2 FY2026, marking a decrease from Rs 11,746.31 lakhs in the previous quarter. This represents a quarter-on-quarter decline of 3.67%. The net profit for the period stood at Rs 200.18 lakhs, down from Rs 274.12 lakhs in the prior quarter, indicating a more substantial decrease of 26.97%.

Earnings Per Share

The basic earnings per share (EPS) for Q2 FY2026 was Rs 3.48, compared to Rs 4.77 in the previous quarter, reflecting the decline in profitability.

Financial Position

As of September 30, 2025, Ambar Protein Industries' balance sheet showed some changes compared to the end of the previous fiscal year:

Particular	As at 30.09.2025	As at 31.03.2025	Change
Total Assets	7,034.49	7,050.38	-0.22%
Non-Current Assets	2,319.28	2,216.42	+4.64%
Current Assets	4,715.21	4,833.95	-2.46%
Total Equity	3,747.64	3,472.51	+7.92%
Non-Current Liabilities	212.84	252.96	-15.86%
Current Liabilities	3,074.01	3,324.91	-7.55%

Notable changes include:

A slight decrease in total assets
An increase in non-current assets, possibly due to capital investments
A reduction in current assets, potentially impacting working capital
A significant increase in total equity, strengthening the company's financial position
Reductions in both non-current and current liabilities, indicating improved debt management

Borrowings and Liquidity

The company's current borrowings decreased to Rs 2,286.04 lakhs from Rs 2,579.28 lakhs as of March 31, 2025, suggesting improved liquidity or debt repayment. Cash and cash equivalents stood at Rs 38.91 lakhs, down from Rs 113.10 lakhs at the end of the previous fiscal year.

Auditor's Review

The limited review conducted by the company's auditors found no material misstatements in the financial results. The results were prepared in accordance with Indian Accounting Standards (Ind AS) and other recognized accounting principles.

Outlook

While Ambar Protein Industries has experienced a decline in revenue and profitability this quarter, the company's improved equity position and reduced liabilities may provide a foundation for future growth. Investors and stakeholders will likely be watching closely to see how the company navigates the challenges reflected in this quarter's results and capitalizes on its strengthened balance sheet in the coming periods.

The company's board of directors approved these unaudited financial results at their meeting held on October 17, 2025, demonstrating their commitment to timely financial reporting and transparency with stakeholders.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-1.60%	0.0%	-9.05%	+32.13%	+52.39%	+3,740.82%

Ambar Protein Industries , a leading manufacturer and seller of edible oil, has announced its unaudited financial results for the first quarter ended June 30, 2025, along with key corporate updates.

Financial Performance

The company reported a mixed financial performance for Q1 FY2026:

Particulars (in ₹ lacs)	Q1 FY2026	Q1 FY2025	YoY Change
Revenue from Operations	11771.19	9304.39	+26.51%
Total Income	11746.31	9326.17	+25.95%
Net Profit	74.63	172.30	-56.69%
Basic EPS (in ₹)	1.30	3.00	-56.67%

Despite a significant increase in revenue, Ambar Protein Industries experienced a decline in profitability compared to the same quarter last year. The company's revenue from operations grew by 26.51% year-over-year to ₹11771.19 lacs, while total income rose by 25.95% to ₹11746.31 lacs. However, net profit for the quarter decreased by 56.69% to ₹74.63 lacs, compared to ₹172.30 lacs in Q1 FY2025.

Corporate Updates

The Board of Directors, in their meeting held on August 14, 2025, approved several key matters:

32nd Annual General Meeting: The notice for the 32nd AGM, scheduled for September 30, 2025, at 10:00 A.M., was approved. The meeting will be held at the company's registered office in Ahmedabad.
Book Closure: The Register of Members and Share Transfer Books will be closed from September 20, 2025, to September 30, 2025 (both days inclusive) for the purpose of the AGM.
E-voting Facility: The company has arranged e-voting facilities through CDSL, with remote e-voting commencing on September 27, 2025, at 9:00 A.M. and concluding on September 29, 2025, at 5:00 P.M.
Board of Directors Report: The Board approved the Directors' Report for the year ended March 31, 2025.

Changes in Independent Directors

Ambar Protein Industries also announced the completion of tenure for three Independent Directors as of August 14, 2025:

Mr. Pradipkumar Sevantilal Shah
Mr. Parimalbhai Bhailalbhai Shah
Mr. Meghalkumar Harishbhai Chakravarti

The company expressed its appreciation for the valuable contributions and guidance provided by these directors during their association with Ambar Protein Industries.